If you want to know more about a drug, Health Canada provides information online through several websites. However, some information appears to be getting harder to find.
Academic rigor, journalistic flair
Articles on Orphan drugs
Displaying all articles
Drug development takes a great deal of time, money and effort. While future profits play a big factor in which diseases gets prioritized, advocacy and research incentives can also tilt the scale.
As Canadians consider possibilities for pharmacare reform in the coming months, they should have access to the best available evidence about how it might work in our country.
Specialty prescription drugs are responsible for countless medical miracles, but their high price tag is the main reason health care costs are out of control.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor, Political Science, McMaster University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
